Latest Breaking News On - A european vision institute - Page 1 : comparemela.com

Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals ACCESSWIRE 04 May 2021, 21:43 GMT+10 A first of its kind synthetic cannabinoid medication to manage eye pain in the veterinary setting OTTAWA, ON / ACCESSWIRE / May 4, 2021 / Tetra Bio-Pharma Inc. ( Tetra or the Company )(TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development is pleased to announce that it has received authorization from the Veterinary Drugs Directorate of Health Canada for a one year extension to continue the clinical trial evaluating the safety, tolerability and potential efficacy of its veterinary ophthalmic drug, PPP-003v, in the treatment of indolent corneal ulcers in companion animals. Canine indolent corneal ulcers occur frequently in specific breeds of dogs

Natalie lerouxTetra bio pharma incDrug administrationHealth canadaJohn wiley sons incRegulation services providerA european vision instituteVeterinary drugs directorate of health canadaTetra bio pharmaVeterinary drugs directorateGuy chamberlandNew animal drug applicationClin tech sm an practCanine corneaJohn wileyPotential therapeutic drugs